Company says details of “when and how best to bring Auvi-Q back to the market” still being worked out.
Kaléo has yet to determine the future of the Auvi-Q and Allerject auto-injector.
Sanofi expert says ‘no evidence’ yet of malfunctions in 26 reported devices; says recall ‘precautionary’.
Sanofi Canada is recalling its auto-injectors from pharmacies, noting 9 suspected malfunctions.
Sanofi US has voluntarily recalled its Auvi‑Q auto-injectors for children and adults due to a dosing issue with the product.
More than 3,000 auto-injectors were recalled in Canada due to a manufacturing defect.
An alarming 63 percent of adults at risk of anaphylaxis do not always carry an auto-injector with them.